Tagged with New Zealand

Faster Access to Medicines: Global Regulatory Authority and HTA Collaborations

Global Faster Access to Medicines: Global Regulatory Authority and HTA Collaborations

Global AstraZeneca’s Anna Litsiou, Carolyn Hynes and Allison Guy, contributing to the September 2024 edition of DIA’s Global Forum magazine, discuss the importance of improving interactions between health technology assessment (HTA) bodies and regulatory authorities. The need to optimize drug development and facilitate faster access for patients has focused discussions…

HTA: Australia’s Independent Review, New Zealand’s New Collaboration

Australia HTA: Australia’s Independent Review, New Zealand’s New Collaboration

Australia Richard Day of the University of New South Wales, writing in the October 2023 edition of DIA’s Global Forum magazine, looks at updates to the health technology assessment (HTA) processes in Australia and New Zealand In April 2023, the Australian Department of Health and Aged Care launched an independent Health…